Home/Filings/4/0001104659-21-031749
4//SEC Filing

KIERNAN ROBERT J 4

Accession 0001104659-21-031749

CIK 0001533615other

Filed

Mar 2, 7:00 PM ET

Accepted

Mar 3, 9:44 PM ET

Size

8.8 KB

Accession

0001104659-21-031749

Insider Transaction Report

Form 4
Period: 2021-03-02
KIERNAN ROBERT J
CFO and Treasurer
Transactions
  • Award

    LTIP Unit (Right to Buy)

    2021-03-02+27,434202,506 total
    Common Stock (27,434 underlying)
  • Award

    LTIP Unit (Right to Buy)

    2021-03-02+28,660231,166 total
    Common Stock (28,660 underlying)
Footnotes (3)
  • [F1]Represents units of limited partnership interest ("LTIP Units") in Global Medical REIT L.P. (the "OP"), the operating partnership of the Issuer. The Issuer's Board of Directors determined on March 2, 2021 that 50% of the LTIP Units vested and became nonforfeitable as a result of meeting certain market-based performance criteria as of December 31, 2021 and 50% of the LTIP Units will vest on March 2, 2022, pursuant to the grant award agreement stipulations. The performance-based LTIP Units were awarded pursuant to the Issuer's 2016 Equity Incentive Plan.
  • [F2]As described in the OP's partnership agreement, vested LTIP Units that have achieved capital account parity may be exchanged at any time after vesting for cash or, at the election of the Issuer, for shares of Common Stock on a one-for-one basis. LTIP Units have no expiration date.
  • [F3]The Issuer's Board of Directors determined on March 2, 2021 that 50% of the LTIP Units vested and became nonforfeitable as a result of meeting certain market based performance criteria as of March 1, 2021 and 50% of the LTIP Units will vest on March 2, 2022, pursuant to the grant award agreement stipulations. The performance-based LTIP Units were awarded pursuant to the Issuer's 2016 Equity Incentive Plan.

Issuer

Global Medical REIT Inc.

CIK 0001533615

Entity typeother

Related Parties

1
  • filerCIK 0001229248

Filing Metadata

Form type
4
Filed
Mar 2, 7:00 PM ET
Accepted
Mar 3, 9:44 PM ET
Size
8.8 KB